Equity Profile

RVTY

Revvity, Inc.

Health CareLife Sciences Tools & Services$13.1B

Jul27Mon

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Revvity, Inc. is a healthcare company focused on life sciences tools and services, providing essential technologies for research and development in the medical field....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well Revvity is managing its costs and generating profits.

$1.22

Revenue

Revenue growth reflects the company's ability to expand its market presence and meet demand for its products and services.

$703M

Wall Street expectations, options signals, track record, and call prep available with Pro.

RVTY Q2-2026 Earnings Preview

Context

Company Snapshot

Revvity, Inc. is a healthcare company focused on life sciences tools and services, providing essential technologies for research and development in the medical field. With a market cap of $13 billion, Revvity plays a critical role in advancing healthcare solutions, especially in an era increasingly driven by innovation and technology.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+6.07%

Avg Stock Reaction

+0.94%

Last Quarter Recap

In Q1-2026, Revvity reported an EPS of $1.04, beating estimates by 2.16%. The stock reacted positively, gaining 6.69% the next day.

Management Promises & Guidance

Continued focus on expanding product offerings.
Commitment to improving operational efficiency.
Plans to enhance customer engagement strategies.

Expectations

Wall Street Expectations

Analysts are generally optimistic about Revvity's upcoming earnings, expecting it to meet or slightly exceed EPS and revenue targets.

Bull Case

If Revvity can deliver strong earnings and show solid revenue growth, it may indicate robust demand for its products, leading to a positive stock reaction.

Bear Case

Conversely, any signs of slowing growth or missed targets could raise concerns about the company's market position and lead to a negative stock reaction.

Key Metrics to Watch

EPS

$1.22

Earnings per share is a key indicator of profitability and will show how well Revvity is managing its costs and generating profits.

Revenue

$703M

Revenue growth reflects the company's ability to expand its market presence and meet demand for its products and services.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Revvity's EPS exceed the consensus estimate of $1.22?

A beat on EPS would reinforce the company's profitability and operational efficiency, which are critical for investor confidence.

What revenue growth will Revvity report compared to the consensus of $703 million?

Revenue growth is essential for understanding the company's market demand and future prospects, impacting stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Revvity's ability to exceed revenue expectations due to recent product launches that have not been fully accounted for.

Supporting Evidence

Revvity has consistently beaten EPS estimates in the past, indicating strong operational performance.

The options market is pricing in a larger move than historical averages, suggesting heightened expectations.

Recent industry trends show increased demand for life sciences tools, which may benefit Revvity.

Key Risk

If Revvity's revenue growth significantly outpaces expectations, it could shift market sentiment dramatically.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching Revvity's ability to maintain strong earnings and revenue growth amid competitive pressures.

Bull Confirmed If

An EPS of $1.25 or higher with revenue exceeding $710 million would confirm the bull case.

Bear Confirmed If

An EPS below $1.19 or revenue below $696 million would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5.73%

Historical Avg

±4.0%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±5.7% while RVTY has averaged ±4.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

50.1%

Calls (5K)P/C Ratio: 1.43Puts (800)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Revvity beats expectations, history suggests the stock could rise by around 0.94%, confirming strong demand and operational success.

In-Line / Cautious

An in-line report may lead to a muted reaction as investors assess management's commentary on future growth prospects.

Miss

If Revvity misses expectations, the stock could drop, reflecting concerns about its growth trajectory, potentially around 3.99% based on historical patterns.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their impact on revenue.
2Any changes in guidance regarding future earnings or revenue.
3Insights into customer engagement strategies and market expansion plans.
4Comments on competitive pressures and how Revvity plans to address them.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aon plc

Company Snapshot

Revvity, Inc. is a healthcare company focused on life sciences tools and services, providing essential technologies for research and development in the medical field....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well Revvity is managing its costs and generating profits.

$1.22

Revenue

Revenue growth reflects the company's ability to expand its market presence and meet demand for its products and services.

$703M

Wall Street expectations, options signals, track record, and call prep available with Pro.

RVTY Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+6.07%

Avg Stock Reaction

+0.94%

Last Quarter Recap

In Q1-2026, Revvity reported an EPS of $1.04, beating estimates by 2.16%. The stock reacted positively, gaining 6.69% the next day.

Management Promises & Guidance

Continued focus on expanding product offerings.
Commitment to improving operational efficiency.
Plans to enhance customer engagement strategies.

Expectations

Wall Street Expectations

Analysts are generally optimistic about Revvity's upcoming earnings, expecting it to meet or slightly exceed EPS and revenue targets.

Bull Case

If Revvity can deliver strong earnings and show solid revenue growth, it may indicate robust demand for its products, leading to a positive stock reaction.

Bear Case

Conversely, any signs of slowing growth or missed targets could raise concerns about the company's market position and lead to a negative stock reaction.

Key Metrics to Watch

EPS

$1.22

Earnings per share is a key indicator of profitability and will show how well Revvity is managing its costs and generating profits.

Revenue

$703M

Revenue growth reflects the company's ability to expand its market presence and meet demand for its products and services.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Revvity's EPS exceed the consensus estimate of $1.22?

A beat on EPS would reinforce the company's profitability and operational efficiency, which are critical for investor confidence.

What revenue growth will Revvity report compared to the consensus of $703 million?

Revenue growth is essential for understanding the company's market demand and future prospects, impacting stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Revvity's ability to exceed revenue expectations due to recent product launches that have not been fully accounted for.

Supporting Evidence

Revvity has consistently beaten EPS estimates in the past, indicating strong operational performance.

The options market is pricing in a larger move than historical averages, suggesting heightened expectations.

Recent industry trends show increased demand for life sciences tools, which may benefit Revvity.

Key Risk

If Revvity's revenue growth significantly outpaces expectations, it could shift market sentiment dramatically.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching Revvity's ability to maintain strong earnings and revenue growth amid competitive pressures.

Bull Confirmed If

An EPS of $1.25 or higher with revenue exceeding $710 million would confirm the bull case.

Bear Confirmed If

An EPS below $1.19 or revenue below $696 million would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5.73%

Historical Avg

±4.0%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±5.7% while RVTY has averaged ±4.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

50.1%

Calls (5K)P/C Ratio: 1.43Puts (800)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Revvity beats expectations, history suggests the stock could rise by around 0.94%, confirming strong demand and operational success.

In-Line / Cautious

An in-line report may lead to a muted reaction as investors assess management's commentary on future growth prospects.

Miss

If Revvity misses expectations, the stock could drop, reflecting concerns about its growth trajectory, potentially around 3.99% based on historical patterns.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their impact on revenue.
2Any changes in guidance regarding future earnings or revenue.
3Insights into customer engagement strategies and market expansion plans.
4Comments on competitive pressures and how Revvity plans to address them.